HSBC Holdings
SUPN icon

HSBC Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History

HSBC Holdings’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424K Buy
+9,027
New +$434K ﹤0.01% 2358
2025
Q3 		– Sell
-39,129
Closed -$1.23M – 3114
2025
Q2 		$1.23M Sell
39,129
-8,274
-17% -$265K ﹤0.01% 1698
2025
Q1 		$1.54M Sell
47,403
-180,627
-79% -$6.4M ﹤0.01% 1572
2024
Q4 		$8.25M Sell
228,030
-22,334
-9% -$786K ﹤0.01% 990
2024
Q3 		$7.8M Buy
250,364
+236,354
+1,687% +$7.38M ﹤0.01% 978
2024
Q2 		$378K Sell
14,010
-173,394
-93% -$5.03M ﹤0.01% 2141
2024
Q1 		$6.38M Buy
187,404
+177,103
+1,719% +$5.27M ﹤0.01% 1016
2023
Q4 		$297K Sell
10,301
-3,063
-23% -$81.2K ﹤0.01% 2288
2023
Q3 		$369K Sell
13,364
-13,553
-50% -$413K ﹤0.01% 2106
2023
Q2 		$803K Buy
26,917
+6,405
+31% +$224K ﹤0.01% 1797
2023
Q1 		$751K Sell
20,512
-6,818
-25% -$262K ﹤0.01% 1898
2022
Q4 		$973K Buy
27,330
+4,134
+18% +$144K ﹤0.01% 1982
2022
Q3 		$791K Buy
23,196
+5,344
+30% +$174K ﹤0.01% 1941
2022
Q2 		$512K Buy
17,852
+861
+5% +$24.7K ﹤0.01% 2314
2022
Q1 		$550K Buy
+16,991
New +$521K ﹤0.01% 2348
2021
Q3 		– Sell
-7,758
Closed -$241K – 3162
2021
Q2 		$241K Buy
+7,758
New +$238K ﹤0.01% 2655
2020
Q4 		– Sell
-15,111
Closed -$318K – 3141
2020
Q3 		$318K Buy
+15,111
New +$343K ﹤0.01% 2217
2018
Q2 		– Sell
-51,590
Closed -$2.36M – 2698
2018
Q1 		$2.36M Buy
+51,590
New +$2.15M ﹤0.01% 1368
2017
Q1 		– Sell
-8,081
Closed -$204K – 2549
2016
Q4 		$204K Buy
+8,081
New +$181K ﹤0.01% 2519

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

HSBC Holdings's SUPN Position: Q2 2026 in Review

HSBC Holdings opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 9,027 shares worth $424K. The stake represents ﹤0.01% of the portfolio and ranks #2358 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in SUPN as recently as Q2 2025.

HSBC Holdings first reported a position in SUPN in Q4 2016 and has held it in 19 quarters since. The position peaked at $8.25M in Q4 2024. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • HSBC Holdings held 9,027 shares of Supernus Pharmaceuticals worth $424K as of Q2 2026.
  • Supernus Pharmaceuticals was a new HSBC Holdings position in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2358 holding.
  • HSBC Holdings first reported a position in Supernus Pharmaceuticals in Q4 2016 and has held it in 19 quarters since.
  • HSBC Holdings's Supernus Pharmaceuticals position peaked at $8.25M in Q4 2024.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.